HK1018741A - Tea, kit and method for treating hemorrhoids - Google Patents

Description

Medicated tea, kit and method for treating hemorrhoids

The present invention relates to a method of treatment of hemorrhoids and their symptoms; and more particularly, the present invention relates to a pharmaceutical composition, a tea, a kit and a method of treatment for hemorrhoidal diseases.

Background

Various diseases of the anorectal region of the human body are characterized by inflammation, itching and ulceration. The anorectal region generally includes the anus, rectum, and lower colon. In particular, hemorrhoids or hemorrhoids are a common condition of the anorectal region and can be located either internally or externally to the anorectal region. Despite their different location, the veins in the anorectal region become inflamed and often lead to itching. Causes of hemorrhoids include predisposing causes such as upright posture, hereditary, occupational, and dietary, constipation, diarrhea, pregnancy, anal infections, pelvic tumors, rectal cancer, heart failure, portal hypertension, vomiting, and physical exertion.

It is well known that many drugs can alleviate these symptoms. Most drugs in the art have varying degrees of efficacy, while few have essentially reduced or completely eliminated the symptoms of hemorrhoids without undesirable side effects.

That is, these known medications have undesirable side effects. It is these undesirable side effects of treatment that often prevent users of such treatments from achieving adequate relief. Therefore, there is a need for a treatment that can substantially or completely remove hemorrhoids without the undesirable side effects associated with treatment.

The prior art has suggested the therapeutic utility of certain unknown compounds of different herbs. In particular, U.S. patent 481,815 to Page et al describes a herbal composition comprising Quillaja saponaria, Acacia constractica and Flourensis Cornua; holder, U.S. patent 272,138, discloses an ointment comprising ailanthus altissima; U.S. patent 3,781,124 to Ponvert discloses a composition comprising a capsicum extract; wood et al, U.S. patent 1,383,896, disclose an ointment comprising an extract of Gnaphalium, balsam of Gilead buds and elderberry bark; U.S. patent 1,890,596 to Zographos discloses an ointment containing powdered mercuric chloride and green wormwood extract; U.S. patent 3,935,310 to Homan discloses a composition comprising an extract of celastrus americana; U.S. patent 4,761,285 to Vasiliou et al discloses a composition comprising extracts of Leptandra root, chickpea and grape seed; U.S. patent 3,464,972 to Rocher discloses a composition comprising an extract of Ficaria raniunculus; meanwhile, U.S. patent 5,002,767 to Masse discloses a composition comprising an extract of the family Oleaceae. None of the compositions so far includes the use of the herbal combination described in the present invention.

In addition, the fact that during defecation the fecal mass expands, tears and irritates the already inflamed swollen hemorrhoidal tissue complicates hemorrhoid treatment. In addition, anal wall protrusion often occurs due to additional muscle tightening resulting from the physical movement of the fecal mass through the swollen inflamed tissue during defecation. In addition, the excretory tract is a site for many organisms that are infectious and like to infiltrate the protruding anal cavities. This infiltration also damages already damaged tissue and worsens the healing process. If the remaining untreated hemorrhoids are often worsened, surgery is required to remove the diseased hemorrhoidal tissue.

Treatment of hemorrhoids tends to focus on topical application of creams and lotions containing medicaments and suppositories, which seek to alleviate itching (Pruritis anil) and/or inflammation. The efficacy of existing treatment techniques in alleviating or treating various symptoms is uncertain. Examples of such creams or lotions are described in: U.S. patent 4,169,143 to Haimowitz, which discloses a method of treating hemorrhoids with a composition comprising vitamin E; montandraud, U.S. patent 3,062,716, which discloses a method of treating hemorrhoids with a composition comprising heparin; U.S. patent No. 3,534,102 to Waldstein, which discloses a method of treating hemorrhoids with a composition comprising the reaction product of elemental iodine and an alkoxylated alkylamine oxide; U.S. patent No. 3,594,473 to Hunger et al, which discloses a method of treating hemorrhoids with a composition comprising the reaction product of ethyl-3, 5, 6-tri-O-benzyl-D-glucofuranoside; amer, U.S. patent No. 5,266,571, discloses a method of treating hemorrhoids with 5-hydroxytryptamine antagonists; packman, U.S. patent 4,945,084, discloses a method of treating hemorrhoids with a disaccharide aluminum polysulfate compound; williams, U.S. patent 4,118,480, discloses a method of treating hemorrhoids with a mixture of compounds; U.S. patent 4,202,825 to Taya discloses a method of treating hemorrhoids with quercetin derivatives; U.S. Pat. No. 4,265,887 to Breskman discloses a method of treating hemorrhoids with a mixture of vitamins; U.S. Pat. No. 4,626,433 to Gold discloses a method of treating hemorrhoids with an ointment comprising aluminum potassium sulfate, linseed oil, methanol, camphor and purified petrolatum; verde, U.S. patent 4,985,257, discloses a method of treating hemorrhoids with a composition comprising a tartaric cream; oakman, U.S. Pat. No. 5,196,405, discloses a method of treating hemorrhoids with a composition comprising a disaccharide aluminum polysulfate compound; us patent 5,234,914 to Gallina discloses a method of treating hemorrhoids with a composition comprising hyaluronic acid; also, U.S. Pat. No. 5,403,867 to Okumura discloses a method of treating hemorrhoids with a composition having antipruritic properties. However, all topical formulations have disadvantages or also irritate already swollen and inflamed tissue by manual application of the drug. In addition, there may be hemorrhoids buried deep within the anorectal cavity that are difficult to access from outside the anorectal cavity for topical application. Thus, there is a need for an edible composition that can be orally administered to alleviate and treat internal hemorrhoids and hemorrhoidal symptoms. The present invention has been made to solve the above-mentioned problems occurring in the art.

Summary of The Invention

It is another object of the present invention to provide an effective hemorrhoid treatment method with low cost and no side effects. There is provided an anti-hemorrhoid composition, tea and kit comprising tea bag comprising (in combination) a first herb of the genus Equisetum and a second herb of the genus Amphipergium of the family Cuachalaceae. The Equisetum herb is selected from the group consisting of Horsetail, Equisetum arvense, Horsetail variety, water Horsetail, cricetera, seaside Horsetail, marsh Horsetail, Equisetum pratense, Horsetail under forest, Equisetum telematoeia, xingan Horsetail, ramose scouring rush, long Horsetail, giant Horsetail, and Equisetum maxim. The herb of genus Equisetum is selected from the group consisting of variant Equisetum boaeale, type Equisetum aiissateum, type Equisetum campestre, type Equisetum diffusum, type Equisetum pseudo-alpestre, type Equisetum pseudo-malvacum, type Equisetum pseudo-varium, type Equisetum ramuuum and type Equisetum varium.

Alternatively, the herbal variety horsetail is selected from the group consisting of variety horseaffine variety, variety horsemtermedium variety, variety horserubusubustum variety, variety horsepolystachyum type, variety horseproliferum type and variety horsepulimum type, the horsetail herb is selected from the group consisting of Equisetum palustre format, and the herb Equisetum tequilibrium is selected from the group consisting of Equisetum palustre, Equisetum palustrum, and Equisetum tequilense. The second herb of the genus ampphisterygium adstringens of the family Cuachalalate is selected from the group consisting of Cuachalalate.

The method for preparing the anti-hemorrhoid composition comprises the steps of mixing an effective amount of a first herbal medicine of the genus equisetum and an effective amount of a second herbal medicine of the genus ampphisterygens of the family Cuachalaceae with a solvent to obtain an herbal mixture. Heating the herbal mixture for an effective period of time to obtain a prepared herbal mixture. Preferably, the solvent is water. Alternatively, the method comprises the steps of soaking the prepared herbal mixture to obtain an impregnated herbal mixture and transferring the impregnated herbal mixture to obtain a substantially purified herbal tea. Optionally, the anti-hemorrhoid composition is packaged. The package comprises tea bag, capsule, tablet, concentrated solution and powder mixture. Preferably, the first and second herbs are separately ground into powders in a blender and then mixed in a 1: 1 volume ratio. Likewise, such pulverized drugs are typically produced in a 1: 2 (first herb: second herb) weight ratio. As an example, the first herb is half as heavy as the second herb.

The method of treating hemorrhoids provided herein comprises the step of periodically ingesting a therapeutically effective amount of the above-described composition. It is a further object of the invention to solve the problems described in the background of the invention section. Objects and features of the present invention, in addition to those specifically set forth above, will become apparent from the detailed description of the invention which follows.

Brief description of the drawingsFIG. 1 is a perspective view of a kit of the invention.

Detailed description of the invention

The present invention is based on the following findings: the processed composition containing as active ingredients the first herb of the genus Equisetum and the second herb of the genus Genrie Juliania (also known as "Cuachalalate") of the family Cuachalalate is ingested to alleviate the symptoms of hemorrhoids and to reduce the swelling of the hemorrhoids. Periodic ingestion of a therapeutically effective amount of this composition alleviates the symptoms of hemorrhoids in a short period of time.

Equisetum herbs are selected from the group consisting of Horsetail (also known as "Canutilo"), Equisetum arvense (also known as "Corn Horsetail" and "Field Horsetail"), Horsetail Variegated (also known as "Common watching Rush"), Equisetum aquaticum, Kanshi, Culcita, Marsh, Equisetum pratense, Equisetum hybridum (also known as "Dwarf Scouringhouse"), Undaria woodenkiana (also known as "Wood Horsetail"), Equisetutumtiem Equisetia, Eleutherochae seu Equisetum, Equisetum majus, and Equisetum maxim.

Equisetum arvense (also known as "Great River Horsetail") is selected from the group consisting of the Boaeale variant of Equisetum arvense, the alpestre type of Equisetum arvense, the Campesre type of Equisetum arvense, the diffusum type of Equisetum arvense, the pseudo-alpestre type of Equisetum arvense, the pseudo-maltivum type of Equisetum arvense, the ramuuum type of Equisetum arvense and the variam type of Equisetum arvense.

The variant horsetail is selected from the group consisting of a variant horsetail affine variant, a variant horsetail intermedium variant, a variant horsetail rubustum variant, a variant horsetail multistachyum type, a variant horsetail proliferum type, and a variant horsetail pumilum type.

The horsetail is selected from the group consisting of Equisetum palustre formual arcuum, Equisetum palustre formual modifier, Equisetum palustre formual fluxes, Equisetum palustre formual nigrens, Equisetum palustre formual modifier, Equisetum palustre formulare, Equisetum palustre formulalosum, Equisetum palustre formulare Verticillatum, and Equisetum palustre formulax.

The Equisetum telematosum is selected from the group consisting of Equisetum telematosum var.

The horsetail is selected from the group consisting of the horsetail jessui variety and the horsetail nelsoni variety.

The shape of the composition to be provided to the consumer is not critical. It may be critical that the composition be supplied as a uniformly mixed powder containing the necessary herbs in the desired proportions. It is also critical that the uniformly mixed powder be capable of combining with a binder and forming water soluble pills and tablets. These pills and tablets may be compressed and formed.

In accordance with the method of the present invention, a therapeutically effective amount of the composition is ingested when suffering from hemorrhoidal symptoms. Typically, the therapeutically effective amount is: one cup of tea is taken every time, three times a day and continuously for one week. Then ingest a cup daily, again for about one week. In cases of severe hemorrhoids, a larger dose of tea needs to be taken for a longer period of time. The user can adjust the dosage to suit different body weights and different severity of symptoms. The treatment is continued until the effects of reducing hemorrhoid symptoms and hemorrhoid swelling are achieved.

The present invention also contemplates the addition of non-objectionable adjuvants to the herbal composition such as natural and artificial sweeteners, inert teas, natural flavors, artificial flavors and coloring agents. The skilled artisan recognizes that the addition of adjuvants can affect the weight and volume of the herbal dose applied to the tissue. Therefore, dosage adjustments that account for the adjuvant are within the skill of the supplier of the adjuvant product.

Fig. 1 illustrates a perspective view of a kit of the invention. The kit contains a container 100 (with a plurality of tea bags 200 therein). The tea bag 200 consists of a permeable membrane or filter made of paper as is well known in the art. Preferably, there are 3 to more than 20 tea bags 200 in the container 100 so that the user has a sufficient number of tea bags 200 (containing the composition described herein) to meet the needs of an adequate, complete treatment. Preferably, a standard dose comprises 28 tea bags. It is understood that any number of tea bags 200 may be used in a kit sufficient to provide a therapeutic effect to a subject. A basic kit comprises a sufficient number of 7 days (21 units), 3 tea bags (3 bags) made per day, and a sufficient number of 7 days (7 units), 1 tea bag (1 bag) made per day, for a minimum of about 28 units. It will be appreciated that the number of tea bags may range from 1 to over 200 bags depending on the needs of the subject.

The examples provided below provide examples of the preparation of the various compositions described herein. Raw ground components and/or pulverized components are used herein. Where teaspoons containing the ingredient are used, the ingredient is typically finely divided particles that are ground into a powder. Where a large spoon of the composition is used, the composition is generally ground and includes coarse particles.Example 1

The anti-hemorrhoid tea is prepared from a mixture of two herbs: a first herb of the genus equisetum and a second herb of the genus genetice Juliania of the family amelipteraceae, ampphibigium prostratingens. In particular, approximately one horizontal spoon of crushed cuachalalate herb and one very high piled spoon of Horsetail herb were added to a teapot with three cups of cold water to produce a mixture. The mixture was boiled for one minute and allowed to soak for five minutes to form a tea. The tea is then poured into a cup through a sifter and allowed to be ingested by the user while the tea is still warm. Three times a day tea (one cup at a time) is ingested for a week. Then ingest a cup daily for an additional period of about a week. At that time the pain of the hemorrhoid will be cured. In cases of severe hemorrhoids, a larger dose of tea is taken for a longer period of time.

Powder of the above mixtureThe batch was also used for the second preparation. The remaining powder from the preparation discussed above was added to three cups of water. The mixture was allowed to soak overnight. The following morning the mixture was boiled and then ingested as discussed above. The primary dose of a course of tea is ingested in varying amounts over a period of about 14 days, the amount also depending on the severity of the hemorrhoids.Example 2

Another example of an anti-hemorrhoid tea is prepared from a mixture of two herbs: a first herb of the genus equisetum and a second herb of the genus genetice Juliania of the family amelipteraceae, ampphibigium prostratingens. Preferably, each cup of solvent, e.g., hot water, is ground to a powdered horsetail and cuachalalate mixture using about 1/2 horizontal teaspoons (or about 1/4 teaspoons of horsetail and about 1/4 teaspoons of cuachalalate). In addition to the above ratios of the first herb to the second herb, two herbs that differ from each other in weight and volume ratios may be used to obtain an effective amount of the combination of herbs. Examples of the weight ratio of the first herbal medicine to the second herbal medicine include a ratio of about one to ten parts of the first herbal medicine to about one to ten parts of the second herbal medicine. Exemplary volume ratios of the first herbal medicine to the second herbal medicine include ratios of about one to ten parts of the first herbal medicine to about one to twenty parts of the second herbal medicine. In severe cases of hemorrhoids, a larger dose of the medicament is taken for a longer period of time.Example 3

A fifty-year-old male subject diagnosed with hemorrhoids including pain and bleeding has not successfully utilized a number of hemorrhoid treatments including hip bath, suppository, ligation. The male subject was treated with the above invention for a period of three weeks according to the protocol described above. Hemorrhoids were successfully cured.Example 4

A male subject has suffered from hemorrhoids for the last 25 years. During the acute hemorrhoid flare-up period, subjects ingest two cups of the above tea daily for a period of ten days. Hemorrhoids were successfully cured.Example 5

A male forty-old subject suffering from hemorrhoids for two weeks ingests three cups of the tea described above per day for a period of two days. Hemorrhoids were successfully cured and hemorrhoidal symptomsAnd (4) disappearing.Example 6

Male subjects in the age of forty-four who suffer approximately one month from hemorrhoids ingest two cups of the tea formulation described above per day (for three days) in conjunction with topical application of the anastrozole cream. Hemorrhoid symptom disappears.

The invention also includes liquid ready-to-serve compositions for alleviating the symptoms of hemorrhoids, such as frozen tea (prepared from powdered ingredients) and the like. In this variant, various additives were added to the first herb of the genus equisetum and the second herb of the genus Generie Juliania of the family amelipterium prostringiensis.

As an example, the acidulant (acidity) is selected from the group consisting of fumaric acid, citric acid, malic acid, and ascorbic acid. Of course, other suitable acidulants may be utilized herein. Ascorbic acid is a required component of the vitamin activity of the composition, also because it acts as an oxygen scavenger.

Alginate was also added thereto. The alginate can include propylene glycol (0.1-0.2%) to delay the tartness of the pulp in the herbal liquid. Additionally, carrageenan is also used in the present invention to improve the mouthfeel of the herbal preparation. Approximately (0.05%) furcellaran was also utilized to stabilize the pulp in the desired beverage. It is also customary to optionally stabilize the formulation with gum arabic.

Optionally, the composition comprises an ingredient selected from the group consisting of vitamins and minerals. Exemplary vitamins included therein include vitamin A, vitamin B complex (and components thereof), vitamin C, vitamin D, vitamin B₂Riboflavin, flavin, nicotinic acid, betulin compound, ascorbic acid, vitamin B₁Thiamine hydrochloride, thiamine chloride, betataxin, betulin, niacinamide, niacin, calcium, pantothenate, pantothenic acid, nicotinamide, vitamin B₆And vitamin E. Examples of inorganic substances include calcium, phosphorus and magnesium, iron, iodine, zinc and copper. Fibers including cellulose of plant origin and other non-digestible cell wall polymers may also be added as desired.

Ready-to-feed variants of the compositions also include optional colorants. The colorant is a natural colorant or an artificial colorant. The colorant is selected from the group consisting of yellow No. 5, yellow No. 6, red No. 2-4, blue No. 1-2, violet No. 1, green No. 3, and orange B. The colorants described herein are only examples of the variety of colorants useful in the present invention. FD and C dyes are also utilized herein as examples. An exemplary use of the colorant herein includes adding an effective amount of colorant to the herbal preparation to obtain the following colorant concentrations in parts per million (ppm): orange flavor: FD and C yellow #6- -in the range of 50-75 ppm; at the same time, approximately 5-10ppm FD and C Red # 40. Cherry flavor: FD and C Red #40- -in the range of 50-75 ppm; at the same time, about 100ppm FD and C blue # 1. Strawberry flavor: FD and C Red #40- -in the range of 50-60 ppm. Lemon flavor: FD and C yellow #5- -were in the range of 10-20 ppm. Kola fruit or root beer (root beer) aroma: the dark brown color is in the range of 200-600 ppm.

The resulting colorant should deliver maximum color to the herbal formulation and dissolve without revealing individual component color. To obtain the maximum color, the dissolved color is added to the solution, followed by a dehumidification operation. The display of the color of the individual components is minimized by use or wet and dry blending.

The herbal preparation may optionally contain natural flavoring agents. Natural flavoring agents include volatile oils, protein hydrolysates, distillates, or any baked, heated or enzymatically hydrolyzed product that retains flavor components derived from spices, vegetables, edible yeast, herbs, bark, buds, roots, leaves, fruits or juice concentrates or similar plant materials.

Alternatively, the herbal formulation is substantially a tablet, capsule, liquid and/or powder. Preparing tablets involves applying high pressure to the herbal formulation to obtain the appropriate size and particle distribution. The herbal preparation is first granulated. When mixing the herbal formulation, granulation is accomplished by slugging and adding a granular liquid by some suitable method. As slugging occurs, the herbal formulation is subjected to tablet pressure which produces a compressed tablet. The tablets are then ground and sieved to produce granules. The aqueous binder is then added to the mixer. After agglomeration, the resulting material is then dried, ground and appropriately screened.

Optionally, EDTA is added as a preservative. In the case of components referred to as comprising herbal preparations, it is possible that the mixture ground to powder consists essentially of, or only of, these components.

Volume ratios are preferred when volume and weight ratios can be used in the practice of the invention and both provide adequate results.

Although only a few preferred embodiments of the present invention have been described above, those of ordinary skill in the art will recognize that: the above-described embodiments may be modified and varied without departing from the central spirit and scope of the invention. The preferred embodiments described above are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.

Claims

Modification according to article 19 of the treaty

1. A composition is mainly composed of a first herb of the genus Equisetum and a second herb of the genus ampphibigium adstringens.

2. A composition according to claim 1, said composition being in solid form.

3. A composition according to claim 2, wherein a solvent is added to said composition.

4. A composition according to claim 3 wherein the solvent is water.

5. The composition according to claim 1, wherein said Equisetum herb is selected from the group consisting of Horsetail, Equisetum, Horsetail variety, aquatic Horsetail, Equisetum, seashore Horsetail, marsh Horsetail, Equisetum, Horsetail, forest Horsetail, Equisetum telematiia, xingan Horsetail, elephantopus, Horsetail, and Equisetum maximum.

6. A composition according to claim 5, wherein said Equisetum arvense is selected from the group consisting of the Boaeale variant of Equisetum arvense, the lepestre type of Equisetum arvense, the campest type of Equisetum arvense, the diffusum type of Equisetum arvense, the pseudo-lepestre type of Equisetum arvense, the pseudo-maltivum type of Equisetum arvense, the pseudo-vacuum type of Equisetum arvense, the ramuuum type of Equisetum arvense and the vacuum type of Equisetum arvense.

7. The composition according to claim 5, wherein said variant horsetail is selected from the group consisting of the variant horsetail affine variant, the variant horsetail intemediate variant, the variant horserubustum variant, the variant horsepolytachyum type, the variant horseprodiff type and the variant horsetail pumilum type.

8. A composition according to claim 5 wherein the horsetail is selected from the group consisting of Equisetum palustre formual arcuatus, Equisetum palustre formafilter, Equisetum palustre formual fluitans, Equisetum palustrremia nigrens, Equisetum palustre multistation, Equisetum palustre formual ramulosum, Equisetum palustre formulant and Equisetum palustre formulary.

9. A composition according to claim 5, wherein the herb Equisetum telematia is selected from the group consisting of Equisetum telematia var.

10. A composition according to claim 5, wherein said horsetail is selected from the group consisting of the horsetail jessui variety and the horsetail nelsoni variety.

11. The composition according to claim 1, wherein said second herb is cuachalalate.

12. The composition according to claim 5, wherein said second herb is cuachalalate.

13. The composition according to claim 6, wherein said second herb is cuachalalate.

14. The composition according to claim 7, wherein said second herb is cuachalalate.

15. The composition according to claim 8, wherein said second herb is cuachalalate.

16. The composition according to claim 9, wherein said second herb is cuachalalate.

17. The composition according to claim 10, wherein said second herb is cuachalalate.

18. The composition according to claim 1, wherein the volume ratio of the first herb of the genus equisetum to the second herb of the genus ampphimatter australens is about 1: 1.

19. The composition according to claim 1, wherein the weight ratio of the first herb of the genus equisetum to the second herb of the genus ampphimatter australens is about 1: 2.

20. The composition according to claim 2, wherein said solid form is selected from the group consisting of a powder, a capsule and a tablet.

21. The composition according to claim 20, wherein said solid form is a powder in a liquid permeable container.

22. A composition according to claim 21 wherein said liquid is water.

Claims (21)

1. An anti-hemorrhoid composition comprises a first herb of the genus Equisetum and a second herb of the genus Amphipterygumadenostingens of the family Cuachalaceae.

2. An anti-hemorrhoid composition according to claim 1, wherein said composition is in the form of a tea.

3. An anti-hemorrhoid composition according to claim 1, wherein said Equisetum herb is selected from the group consisting of Horsetail, Equisetum arvense, Horsetail variety, Equisetum aquaticum, Equisetum kawachii, Equisetum seafarina, Equisetum palustre, Equisetum pratense, Equisetum arvense, Equisetum hybridum, Equisetum hiemali, Equisetum falcatum, Equisetum hiemalim, Equisetum giganteum, Equisetum falcatum, and Equisetum maximum.

4. An anti-hemorrhoid composition according to claim 3, wherein said Equisetum arvense is selected from the group consisting of the Boaeale variant of Equisetum arvense, the lepestre type of Equisetum arvense, the campestre type of Equisetum arvense, the diffusum type of Equisetum arvense, the pseudo-alpestre type of Equisetum arvense, the pseudo-maltivum type of Equisetum arvense, the pseudo-varium type of Equisetum arvense and the varium type of Equisetum arvense.

5. An anti-hemorrhoid composition according to claim 3, wherein said variant horsetail is selected from the group consisting of variant horsetail affine variant, variant horsetail intermedium variant, variant horserubustum variant, variant horsepolytachyum type, variant horseprodiff type and variant horsepumilum type.

6. An anti-hemorrhoid composition according to claim 3, wherein said swamp scouring rush is selected from the group consisting of Equisetum palustre formual, Equisetum palustre forms, Equisetum palustre formual, Equisetum palustre nigrides, Equisetum palustre polystemeon, Equisetum palustre formual ramulosum, Equisetum palustre formual and Equisetum palustre formual.

7. An anti-hemorrhoid composition according to claim 3, wherein said herb Equisetum telematia is selected from the group consisting of Equisetum telematia var. Pauciramosum and Equisetum telematia multiramesum types.

8. An anti-hemorrhoid composition according to claim 3, wherein said horsetail is selected from the group consisting of the horsetail jessui variety and the horsetail nelsoni variety.

9. An anti-hemorrhoid kit comprising a plurality of tea bags, each of said tea bags having a first herb of the genus Equisetum and a second herb of the genus Amphipterygium adenostingens of the family Cuachalaceae.

10. A method for reducing hemorrhoids, the method comprising the step of periodically ingesting a therapeutically effective amount of the composition of claim 1.

11. A method according to claim 10, wherein the step of periodically ingesting a composition of claim 1 comprises ingesting said composition in the range of about 1 to 30 days.

12. A method according to claim 10, wherein said therapeutically effective amount is a weight ratio of about one to five parts of the first herb of the genus equisetum to about one to five parts of the second herb of the genus ampphipterygumadenostingens of the family laeaceae.

13. A method according to claim 10, wherein said therapeutically effective amount is a volume ratio of about one part of a first herb of the genus equisetum to about one part of a second herb of the genus ampphipterygium of the family furacaceae.

14. A method for preparing an anti-hemorrhoid composition, the method comprising the steps of mixing a therapeutically effective amount of a first herb of the genus Equisetum, a therapeutically effective amount of a second herb of the genus Amphipterygium of the family Cuachalaceae, and a solvent to obtain a mixed herb; and heating said mixed herbs for an effective period of time to obtain prepared mixed herbs.

15. A method according to claim 14, wherein said effective amount is a volume ratio of about one to five parts of the first herb of the genus equisetum to about one to five parts of the second herb of the genus ampphipterygumadenostingens of the family laeaceae.

16. The method according to claim 14, wherein said solvent comprises at least water.

17. The method according to claim 14, wherein said solvent consists essentially of water.

18. A method according to claim 14, wherein said solvent comprises at least water and said effective period of time is at least the time required to boil said prepared mixed herbs.

19. The method according to claim 14, further comprising the step of soaking the prepared mixed herbs to obtain a soaked mixed herbs.

20. The method according to claim 14, further comprising the step of filtering the soaked mixed herbs to obtain a purified herbal tea.

21. An anti-hemorrhoid composition according to claim 1, wherein the composition is a packaged composition selected from the group consisting of tea bags, capsules, tablets, concentrated liquids and powdered mixes.